rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0061700,
umls-concept:C0205216,
umls-concept:C0205217,
umls-concept:C0332307,
umls-concept:C0439792,
umls-concept:C0439793,
umls-concept:C0439849,
umls-concept:C0441889,
umls-concept:C0445223,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1956346
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-10-5
|
pubmed:abstractText |
This cross-sectional study aimed at evaluating the possible association of serum levels of glycated albumin (GA) and endogenous secretory RAGE (esRAGE) with angiographically significant coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM) and non-diabetic patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1879-1484
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
206
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
540-5
|
pubmed:meshHeading |
pubmed-meshheading:19368923-C-Reactive Protein,
pubmed-meshheading:19368923-China,
pubmed-meshheading:19368923-Coronary Angiography,
pubmed-meshheading:19368923-Coronary Artery Disease,
pubmed-meshheading:19368923-Cross-Sectional Studies,
pubmed-meshheading:19368923-Diabetes Mellitus, Type 2,
pubmed-meshheading:19368923-Glycosylation End Products, Advanced,
pubmed-meshheading:19368923-Humans,
pubmed-meshheading:19368923-Interleukin-6,
pubmed-meshheading:19368923-Male,
pubmed-meshheading:19368923-Receptors, Immunologic,
pubmed-meshheading:19368923-Serum Albumin,
pubmed-meshheading:19368923-Tumor Necrosis Factor-alpha
|
pubmed:year |
2009
|
pubmed:articleTitle |
Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes.
|
pubmed:affiliation |
Department of Cardiology, Rui Jin Hospital, 197 Rui Jin Road II, Shanghai 200025, PR China.
|
pubmed:publicationType |
Journal Article
|